- Report
- February 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- March 2021
- 83 Pages
Asia Pacific
From €1442EUR$1,500USD£1,236GBP
- Report
- February 2022
- 39 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Report
- March 2024
- 111 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Drug Pipelines
- July 2020
- 46 Pages
Global
From €1922EUR$2,000USD£1,648GBP
Guaifenesin is a drug used to treat respiratory illnesses such as the common cold, bronchitis, and sinusitis. It is an expectorant, meaning it helps to loosen and thin mucus in the airways, making it easier to cough up. Guaifenesin is available in many forms, including tablets, capsules, syrups, and liquids. It is often combined with other medications, such as decongestants, to treat more severe respiratory illnesses. Guaifenesin is generally considered safe and effective, and is available over-the-counter in most countries.
The Guaifenesin market is a large and growing one, with many companies offering products containing the drug. Some of these companies include GlaxoSmithKline, Pfizer, Novartis, Merck, and Johnson & Johnson. Show Less Read more